Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Anti-Cancer Drugs|July 23, 2004
No anti-apoptotic effects of single copies of mutant p53 genes in drug-treated tumor cellsClaudia Fritzsche, Geraldine Zeller, Karl X Knaup, et al.
Frontiers in Physiology|June 12, 2014
Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signalingJörg Reichrath, Sandra Reichrath, Kristina Heyne, et al.
Cell Cycle (Georgetown, Tex.)|July 11, 2013
A novel mechanism of crosstalk between the p53 and NFκB pathways: MDM2 binds and inhibits p65RelAKristina Heyne, Christine Winter, Fabian Gerten, et al.
Mobile DNA|March 10, 2015
HERV-K(HML-2) rec and np9 transcripts not restricted to disease but present in many normal human tissuesKatja Schmitt, Kristina Heyne, Klaus Roemer, et al.
Cell Cycle (Georgetown, Tex.)|May 14, 2015
MDM2 binds and inhibits vitamin D receptorKristina Heyne, Tessa-Carina Heil, Birgit Bette, et al.
Molecular Cancer|June 13, 2008
Resistance of mitochondrial p53 to dominant inhibitionKristina Heyne, Katrin Schmitt, Daniel Mueller, et al.
Cell Cycle (Georgetown, Tex.)|April 21, 2016
microRNA-496 - A new, potentially aging-relevant regulator of mTORClaudia Rubie, Kathrin Kölsch, Beata Halajda, et al.
Pageof 6